Mid-August 2023, Imaging Biometrics, IQ-AI’s principal portfolio investment, announced a new distribution partnership with GE Healthcare Technologies (GEHC: Nasdaq). Pacts with GE and two other top-tier players in the medical imaging sector gives the Company access to an impressive footprint in the medical imaging sector well beyond what might otherwise be possible for a newcomer […]
Category: IQAI-IQAIF
Update Report – IQ-AI, Ltd (IQAI, IQAIF) – May 30, 2023
IQ-AI, Ltd. provided clues to its present market activities through a report of financial results for the second half and full-year ending December 2022. The Company appears to have made progress on several fronts, moving closer to completing its first clinical trial for an important brain tumor treatment and preparing an application for approval of […]
Update Report – IQ-AI, Ltd. (IQAI, IQAIF)
Shareholders were recently treated to encouraging news from IQ-AI’s main portfolio holding in artificial intelligence. Mid-April 2023, Imaging Biometrics announced a new partnership with Prism Clinical Imaging, a provider of brain mapping software. Prism intends to integrate Imaging Biometrics’ quantitative solutions into its software product. Brain image clinical reports generated by Prism’s applications will be […]
Update Report – IQ-AI Ltd. (IQAIF, IQAI)
IQ-IA, Ltd. recently received approval by the U.S. Federal Drug Administration of orphan drug status for the Company’s gallium maltolate compound for the treatment of glioblastoma multiform brain cancer. Once approved orphan drugs get market exclusivity for as long as seven years, providing IQ-IA competitive protection for an extended period of time, potentially enhancing sales […]
Update Report – IQ-IA, Ltd. (IQIA, IQIAF)
IQ-AI Ltd. reported financial results for the first six months of 2022, confirming 7.2% year-over-year growth at the topline at the Company’s principal portfolio investment in Imaging Biometrics. Investors might have liked a higher number than GB£ 255,609 in the six-month period, but the slightly faster growth rate than the radiology solutions sector suggests Imaging […]